ID: ALA512231

Max Phase: Preclinical

Molecular Formula: C20H21NO2S

Molecular Weight: 339.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCN(c1ccccc1)S(=O)(=O)c1cccc2ccccc12

Standard InChI:  InChI=1S/C20H21NO2S/c1-2-3-16-21(18-12-5-4-6-13-18)24(22,23)20-15-9-11-17-10-7-8-14-19(17)20/h4-15H,2-3,16H2,1H3

Standard InChI Key:  NHVZAKJUVOUBEJ-UHFFFAOYSA-N

Associated Targets(Human)

Nuclear receptor subfamily 1 group I member 3 655 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Constitutive androstane receptor 427 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 339.46Molecular Weight (Monoisotopic): 339.1293AlogP: 4.84#Rotatable Bonds: 6
Polar Surface Area: 37.38Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 5.00CX LogD: 5.00
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.64Np Likeness Score: -1.31

References

1. Jyrkkärinne J, Windshügel B, Rönkkö T, Tervo AJ, Küblbeck J, Lahtela-Kakkonen M, Sippl W, Poso A, Honkakoski P..  (2008)  Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship.,  51  (22): [PMID:18983136] [10.1021/jm800731b]

Source